Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG) | Zendy

Ewa LechMarańda | Zendy; Marek Seweryn | Zendy; Sebastian Giebel | Zendy; Jerzy Hołowiecki | Zendy; Beata PiątkowskaJakubas | Zendy; Joanna Węgrzyn | Zendy; Aleksander B. Skotnicki | Zendy; Marek Kiełbiński | Zendy; Kazimierz Kuliczkowski | Zendy; Monika Paluszewska | Zendy; W Wiktor-Jędrzejczak | Zendy; Magdalena Dutka | Zendy; Andrzej Hellmann | Zendy; Marcin Flont | Zendy; Barbara Zdziarska | Zendy; Grażyna Pałynyczko | Zendy; L Konopka | Zendy; Tomasz Szpila | Zendy; Krzysztof Gawroński | Zendy; K Sułek | Zendy; J Sokołowski | Zendy; Janusz Kłoczko | Zendy; Krzysztof Warzocha | Zendy; Tadeusz Robak | Zendy

Open Access

Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG)

Author(s) -

Ewa LechMarańda,

Marek Seweryn,

Sebastian Giebel,

Jerzy Hołowiecki,

Beata PiątkowskaJakubas,

Joanna Węgrzyn,

Aleksander B. Skotnicki,

Marek Kiełbiński,

Kazimierz Kuliczkowski,

Monika Paluszewska,

W Wiktor-Jędrzejczak,

Magdalena Dutka,

Andrzej Hellmann,

Marcin Flont,

Barbara Zdziarska,

Grażyna Pałynyczko,

L Konopka,

Tomasz Szpila,

Krzysztof Gawroński,

K Sułek,

J Sokołowski,

Janusz Kłoczko,

Krzysztof Warzocha,

Tadeusz Robak

Publication year - 2009

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2009.02.021

Subject(s) - daunorubicin , cladribine , medicine , cytarabine , myeloid leukemia , leukemia , oncology

The addition of cladribine to the standard regimen consisting of daunorubicin and cytarabine has been reported to increase the efficacy of induction therapy in acute myeloid leukemia (AML). The goal of this study was to determine the effect of this modification on the incidence and spectrum of infectious complications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research